CT
BIIB icon

Clearstead Trust’s Biogen BIIB Stock Holding History

Clearstead Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Hold
50
– – ﹤0.01% 606
2026
Q1 		$9.17K Hold
50
– – ﹤0.01% 604
2025
Q4 		$8.8K Buy
50
+9
+22% +$1.47K ﹤0.01% 622
2025
Q3 		$5.74K Sell
41
-41
-50% -$5.54K ﹤0.01% 733
2025
Q2 		$10.3K Buy
82
+55
+204% +$6.85K ﹤0.01% 583
2025
Q1 		$3.69K Buy
+27
New +$3.86K ﹤0.01% 673
2018
Q1 		– Sell
-417
Closed -$133K – 125
2017
Q4 		$133K Sell
417
-3
-0.7% -$962 0.09% 119
2017
Q3 		$132K Hold
420
– – 0.1% 128
2017
Q2 		$114K Buy
+420
New +$111K 0.09% 122

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clearstead Trust's BIIB Position: Q2 2026 in Review

Clearstead Trust held its Biogen (BIIB) position steady in Q2 2026 at 50 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Clearstead Trust first reported a position in BIIB in Q2 2017 and has held it in 9 quarters since. The position peaked at $133K in Q4 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Clearstead Trust held 50 shares of Biogen worth $10.8K as of Q2 2026.
  • Clearstead Trust left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #606 holding.
  • Clearstead Trust first reported a position in Biogen in Q2 2017 and has held it in 9 quarters since.
  • Clearstead Trust's Biogen position peaked at $133K in Q4 2017.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.